Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The UK government and life sciences industry leaders are investing more than £1 billion to support healthcare innovation and research aimed at using AI for early disease detection.
A significant portion of healthcare workers are born outside the U.S., according to a new study published by Harvard Medical School researchers in JAMA.
As healthcare leaders prioritize reducing costs, one executive believes the way to get there involves wearable devices with sensors, digital assistants and AI, according to a report by The Wall Street Journal.
Cardiologs co-founder and CEO Yann Fleureau was named the European Innovator of the Year by MIT Technology Review, which also included the French native on its list of the top 35 European innovators under the age of 35.
The FDA is speeding up the review process for new software that uses AI to help radiologists diagnose chronic thromboembolic pulmonary hypertension (CTEPH), pharmaceutical company Bayer announced Dec. 3.
The National Institutes of Health (NIH) and tech company NVIDIA are partnering to create AI tools for clinical trials focused on brain and liver cancer.
